查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1928612

醫療MCS設備市場按產品類型、技術、行動性、應用和最終用戶分類，全球預測，2026-2032年

Medical MCS Device Market by Product Type, Technology, Mobility, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療 MCS 設備市場價值將達到 22.8 億美元，到 2026 年將成長至 24.6 億美元，到 2032 年將達到 38.2 億美元，複合年成長率為 7.60%。

關鍵市場統計數據
基準年 2025 22.8億美元
預計年份：2026年 24.6億美元
預測年份 2032 38.2億美元
複合年成長率 (%) 7.60%

對影響現代機械循環輔助裝置應用的臨床因素、技術進步、法規環境和相關人員責任進行重點分析

機械循環支援裝置在先進心臟病學、重症監護和生物醫學工程的交叉領域發揮核心作用。這項涵蓋體外氧合平台、植入式心室輔助裝置和全人工心臟的技術體系，旨在滿足晚期心臟衰竭和急性心肺功能不全患者維持血流動力學穩定的迫切臨床需求。臨床決策越來越重視及時提供循環支持，以作為復健橋樑、移植橋樑、根治性治療或安寧療護的手段，而裝置的選擇則取決於疾病嚴重、患者生理狀況和治療環境。

循環支援領域正在經歷技術、臨床、監管和供應鏈變革的融合，這些變革正在重塑設備配置、數據整合和護理模式。

機械循環支持系統正經歷變革性的轉變，重新定義了設備設計、照護模式和商業策略。其中一個顯著的變化是，大型固定式系統正穩步向更緊湊、更節能的平台過渡，從而實現長期門診管理。泵浦技術和材料科學的進步進一步推動了這一趨勢，降低了血栓形成風險並延長了設備的使用壽命。同時，連續流動動態和控制演算法的創新正在提高生理響應性，使其能夠更好地適應患者的活動水平，從而改善患者的生活品質。

評估不斷變化的關稅政策對整個設備供應鏈的籌資策略、供應商多元化、製造本地化和採購韌性的影響

跨境關稅和政策措施會改變貿易格局，對醫療設備製造商、供應商和醫療系統採購者產生可衡量的營運影響。關稅調整實施後，採購團隊和製造負責人必須重新評估零件採購、庫存策略和供應商契約，以維持成本可控性和供應連續性。關稅導致的投入成本變化主要促使企業採取兩種策略因應措施：一是盡可能提高關鍵零件生產的在地化程度；二是實現供應商網路多元化，以降低單一來源風險。這兩種應對措施都需要前期投資，用於尋找新的供應商、檢驗流程控制以及更新監管文件，以提供製造地和材料規格等資訊。

對設備設計、臨床檢驗、服務模式和報銷策略的影響因產品類型、應用、技術、最終用戶和行動配置而異

我們對機械循環支援裝置的市場結構進行了分析，並根據臨床和商業性細分，揭示了不同產品類別、應用、技術、最終用戶和移動方式所帶來的獨特需求促進因素和營運重點。產品系列包括雙心室輔助裝置、植入式左心室和右心室輔助裝置、體外膜氧合（ECMO）以及全人工心臟解決方案，每種產品在設計、植入和追蹤方面都有其獨特的要求。臨床應用領域涵蓋復健過渡（包括長期和短期）、移植過渡、合格移植患者的最終治療以及安寧療護，其主要目標是緩解症狀並提高生活品質。技術選擇（包括連續流配置，如軸流和離心流，以及脈動流系統）直接影響抗凝血策略、血流動力學特徵和病患監測通訊協定。

區域法規結構、臨床基礎設施、報銷機制和製造地對醫療器材採用和商業化策略的綜合影響

區域趨勢對監管路徑、臨床應用、製造地和報銷模式有顯著影響。在製定商業化和供應策略時，必須認真考慮這些差異。在美洲，成熟的三級醫療網路和高容量的移植中心對植入式心室輔助裝置和先進的體外循環支援設備有著集中的需求。支付體系和醫院資本規劃實務影響著設備的生命週期管理以及對整體醫療成本的關注。在歐洲、中東和非洲地區，不同的法規環境和醫院基礎設施造成了不同的市場接受度曲線。雖然歐洲部分地區正在快速推廣門診和居家治療項目，但中東和北非市場優先考慮可擴展的急性護理解決方案和醫護人員隊伍建設，以擴大服務覆蓋範圍。

我們在技術差異化、策略合作、證據產生和全面的售後服務方面擁有競爭優勢，使我們能夠獲得臨床和商業性優勢。

機械循環支援領域的競爭格局呈現出多元化的特點，既有老牌醫療設備巨頭，也有敏捷的專業創新者、學術型新創公司和契約製造，它們都在加速產品創新和服務差異化。主要企業專注於發展其核心技術平台，推動諸如具有最佳化血液相容性的驅動系統、緊湊型能量和溫度控管解決方案以及支援遠端監測和預測性維護的嵌入式感測器套件等技術。同時，規模較小的公司則傾向於專注於有望出現顛覆性創新的細分領域，例如全穿戴式式循環支援設備、用於減少血栓症形成的新型生物材料以及實現封閉回路型血流動力學控制的軟體架構。

醫療設備領導者可採取切實可行的策略重點，整合臨床證據、生產韌性、數位化能力和支付方合作，以實現持續應用。

為了贏得臨床信賴和機構認可，產業領導者應採取一套協調一致的策略，將臨床證據、生產韌性和商業性可行性結合。首先，投資於有針對性的臨床研究和註冊登記，以證明設備在與機構合作夥伴最相關的特定應用中的性能，涵蓋從短期急性支持到長期臨終關懷等各種場景。同時，加快人體工學測試和臨床工作流程整合，以減輕訓練負擔，並最大限度地減少門診和居家照護過渡期間的不利事件。其次，努力實現供應商多元化和區域化生產，以降低政策主導的成本波動和供應中斷風險。盡可能推進二級供應商資格認證，並考慮策略性庫存佈局，以確保醫療服務的連續性。

一項全面且檢驗的研究途徑整合了臨床醫生參與、系統性的二級文獻綜述、供應鏈分析以及交叉檢驗的分析方法，以確保研究結果的可靠性。

我們採用嚴謹的調查方法來分析機械循環支援技術，該方法結合了與關鍵相關人員的直接對話、系統的二手文獻綜述以及數據三角驗證，以檢驗研究結果並識別挑戰。主要研究包括對心臟外科醫生、心臟科醫生、重症循環系統技師和護理管理人員進行結構化訪談，以及與供應鏈經理、生物醫學工程師和醫院採購負責人進行討論，以了解操作流程。二手研究整合了同行評審的臨床文獻、監管申報文件、臨床試驗註冊資訊、醫療設備標籤和說明書以及相關監管機構發布的標準，以闡明產品功能和安全性方面的考慮。

整合臨床、營運和商業性需求，制定切實可行的藍圖，指導醫療設備創新，進而為病患和醫療機構帶來永續的成果。

機械循環支援領域正處於一個轉折點，技術進步、不斷演進的護理模式和政策趨勢在此交匯，為相關人員帶來機會和挑戰。泵浦設計、遠端監測和生物相容性材料的進步正在拓展設備的臨床效用，並催生出傳統重症監護環境之外的新型護理路徑。同時，管理體制、採購行為和基礎設施能力的區域差異要求制定個人化的商業化和部署策略。影響貿易和關稅環境的政策變化進一步凸顯了製造和採購彈性對於維持設備供應和成本效益的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的醫療MCS設備市場

  • 雙心室輔助裝置
  • 體外膜氧合器
  • 左心室輔助裝置
  • 右心輔助裝置
  • 人工心臟

9. 按技術分類的醫療MCS設備市場

  • 連續流
    • 軸流式
    • 離心流
  • 脈動流

第10章：醫療MCS設備市場趨勢

  • 攜帶式的
    • 嵌入式
    • 穿戴式裝置
  • 固定式

第11章 依應用分類的醫療MCS設備市場

  • 通往復健的橋樑
    • 長期
    • 短期
  • 移植橋樑
  • 最終治療
  • 安寧療護

第12章 依最終使用者分類的醫療MCS設備市場

  • 門診治療中心
  • 居家醫療環境
  • 醫院
    • 心臟監護病房
      • 成人加護病房
      • 兒童加護病房
    • 加護病房

第13章 醫療MCS設備市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫療MCS設備市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國醫療MCS設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫療MCS設備市場

第17章：中國醫療MCS設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Abiomed, Inc.
  • Alcon, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • GE HealthCare
  • Getinge AB
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic plc
  • Nipro Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • SynCardia Systems, LLC
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.
  • ZOLL Medical Corporation
Product Code: MRR-92740D85F068

The Medical MCS Device Market was valued at USD 2.28 billion in 2025 and is projected to grow to USD 2.46 billion in 2026, with a CAGR of 7.60%, reaching USD 3.82 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.28 billion
Estimated Year [2026] USD 2.46 billion
Forecast Year [2032] USD 3.82 billion
CAGR (%) 7.60%

A focused orientation to the clinical drivers, technological progress, regulatory context, and stakeholder responsibilities shaping modern mechanical circulatory support device adoption

Mechanical circulatory support devices occupy a central role at the intersection of advanced cardiology, critical care, and biomedical engineering. This body of technologies - spanning extracorporeal oxygenation platforms, implantable ventricular assist devices, and fully artificial hearts - responds to an urgent clinical imperative: sustaining hemodynamic stability in patients with advanced heart failure and acute cardiopulmonary collapse. Clinical decision pathways increasingly prioritize timely circulatory support as a bridge to recovery, a bridge to transplantation, destination therapy, or palliative relief, and the choice of device is governed by acuity, patient physiology, and care setting.

Against this clinical backdrop, manufacturers and health systems are navigating converging trends in miniaturization, biocompatible materials, power management, and control software. These developments are reshaping device usability and expanding opportunities for ambulatory and home-based management. Simultaneously, evolving regulatory expectations and the maturation of post-market surveillance demand more robust real-world evidence and human factors validation. As a result, stakeholders from clinicians and device engineers to procurement officers and payers must align clinical evidence strategies, training pathways, and service models to ensure safe, effective, and sustainable adoption. The following analysis synthesizes these dynamics, articulates pivotal shifts in the landscape, and frames actionable priorities for clinical and commercial leadership.

Key technological, clinical, regulatory, and supply chain transformations converging to reshape device form factors, data integration, and care models in circulatory support

The mechanical circulatory support ecosystem is undergoing transformative shifts that are redefining device design, care delivery models, and commercial strategies. A prominent change is the steady move from large, stationary systems toward more compact, energy-efficient platforms enabling longer-term outpatient management. This trend is reinforced by advances in pump technology and materials science that reduce thrombogenicity and extend device longevity. Concurrently, innovations in continuous flow dynamics, and control algorithms have enhanced physiological responsiveness, enabling smoother integration with patient activity levels and improving quality-of-life outcomes.

Another critical evolution is the integration of digital health capabilities: embedded sensors, remote telemetry, and predictive analytics are beginning to inform clinical decision-making and proactive device management. These capabilities support earlier detection of complications, reduce readmissions, and create new service layers around remote monitoring and algorithm-driven alerts. Regulatory pathways have adapted in parallel, with an increased focus on post-market data and clinical registries that validate real-world performance. Supply chains and manufacturing models are also shifting; there is greater emphasis on regional sourcing, modular production, and robust quality systems that can scale rapidly in response to demand fluctuations. Together, these shifts are raising the bar for clinical evidence, interoperability, and lifecycle services, prompting manufacturers and providers to rethink product roadmaps, reimbursement discussions, and long-term patient support strategies.

Assessment of how evolving tariff policies influence sourcing strategies, supplier diversification, manufacturing localization, and procurement resilience across device supply chains

Policy actions that alter cross-border tariffs and trade dynamics introduce measurable operational effects for device manufacturers, suppliers, and health system purchasers. When tariff adjustments are introduced, procurement teams and manufacturing leaders must reassess component sourcing, inventory strategies, and supplier contracts to preserve affordability and supply continuity. Tariff-driven input cost changes tend to prompt two strategic responses: increased localization of critical component production where feasible, and the diversification of supplier networks to mitigate single-source risk. Both responses require upfront investment in qualifying new vendors, validating process controls, and updating regulatory filings that reference manufacturing sites and material specifications.

Hospitals and integrated health systems that operate constrained capital budgets may react to cost pressures by extending device lifecycles through more rigorous maintenance and reuse protocols where clinically appropriate, or by prioritizing devices with lower total cost of care implications. Clinical trial sponsors and investigators may also confront higher operational expenses for imported specialized equipment, influencing site selection and study timelines. From a commercial standpoint, companies are likely to revisit pricing strategies, service contract structures, and the geographic allocation of inventory to optimize duty exposure. Importantly, tariff shifts often accelerate conversations about regional manufacturing hubs and contract manufacturing relationships, as these arrangements can reduce exposure to import duties and shorten lead times. To preserve patient access and clinical continuity, stakeholders must adopt nimble sourcing, transparent cost modeling, and collaborative procurement frameworks that accommodate policy variability while safeguarding quality and safety standards.

Segment-driven implications for device engineering, clinical validation, service models, and reimbursement strategies across product types, applications, technologies, end users, and mobility configurations

Decomposing the mechanical circulatory support landscape through clinical and commercial segmentation reveals differentiated demand drivers and operational priorities across product classes, applications, technologies, end users, and mobility profiles. Product portfolios span devices designed for biventricular support, implantable left ventricular assist devices, right ventricular assist devices, extracorporeal membrane oxygenation systems, and total artificial heart solutions, each with distinct engineering, implantation, and follow-up requirements. Clinical applications encompass the bridge to recovery pathway in both long-term and short-term contexts, bridge to transplant, destination therapy for patients ineligible for transplant, and palliative care where symptom relief and quality of life are the primary objectives. The choice of technology-between continuous flow configurations, which include axial flow and centrifugal flow variants, and pulsatile flow systems-directly affects anticoagulation strategies, hemodynamic profiles, and patient monitoring protocols.

End-user environments shape usability and service needs; ambulatory care centers and home care settings demand simplified interfaces, remote monitoring, and compact power systems to facilitate patient mobility, whereas hospital deployments concentrate in cardiac care units and intensive care units, with cardiac care further divided into adult and pediatric intensive care contexts that have specific size, hemodynamic, and training considerations. Mobility preferences bifurcate into portable and stationary offerings, with portable devices further categorized into implantable and wearable forms that influence battery technology, human factors design, and maintenance workflows. Recognizing these segment-level distinctions enables manufacturers to prioritize clinical evidence generation tailored to use cases, design service models that match end-user capabilities, and align reimbursement narratives with the operational realities of selected care settings and technologies.

How regional regulatory frameworks, clinical infrastructure, reimbursement mechanisms, and manufacturing footprints collectively influence device adoption and commercialization tactics

Regional dynamics exert a powerful influence on regulatory pathways, clinical adoption, manufacturing footprints, and reimbursement models, and these differences merit careful consideration when planning commercialization and supply strategies. In the Americas, mature tertiary care networks and high-volume transplant centers create concentrated demand for implantable ventricular assist systems and advanced extracorporeal support. Payment systems and hospital capital planning practices influence device lifecycle management and the emphasis placed on total cost of care. In Europe, Middle East & Africa, heterogeneous regulatory environments and variable hospital infrastructure drive divergent adoption curves; parts of Europe demonstrate rapid uptake of ambulatory and home-based programs, while markets in the Middle East and Africa prioritize scalable acute care solutions and workforce training to expand access.

Across Asia-Pacific, rapid investment in specialized cardiac centers, expanding middle-class patient populations, and proximity to manufacturing hubs stimulate both domestic innovation and regional production partnerships. Telemedicine penetration and home-care capabilities are rising across several Asia-Pacific markets, enabling earlier discharge models and remote follow-up services. Importantly, regional tariff regimes and trade agreements further shape where manufacturers locate production and how they price devices to maintain competitive access. Understanding these regional nuances allows clinical leaders and commercial teams to tailor evidence generation, field service models, and partner selection to local regulatory expectations, reimbursement mechanisms, and care delivery practices.

Competitive dynamics that prioritize technological differentiation, strategic partnerships, evidence generation, and comprehensive aftermarket services to secure clinical and commercial advantage

Competitive dynamics in the mechanical circulatory support arena are defined by a mix of established medical device incumbents, agile specialty innovators, academic spinouts, and contract manufacturers that together accelerate product innovation and service differentiation. Leading organizations focus on advancing core technology enablers-drive systems with optimized hemocompatibility profiles, compact energy and thermal management solutions, and embedded sensor suites that support remote monitoring and predictive maintenance. At the same time, smaller and mid-stage companies often concentrate on disruptive niches such as fully wearable circulatory assist devices, novel biomaterials to reduce thrombosis, or software architectures that facilitate closed-loop hemodynamic control.

Strategic collaboration is increasingly common: partnerships with clinical networks accelerate real-world evidence collection, alliances with contract manufacturers support scalable production, and cooperation with software firms enhances data analytics and interoperability. Aftermarket services and training programs have emerged as differentiators, with comprehensive clinician education, rapid-response field engineering, and remote telemetry services improving patient outcomes and device uptime. For commercial leaders, prioritizing differentiated clinical value propositions, investing in evidence generation to substantiate safety and usability claims, and building resilient supply and service networks are central to maintaining a competitive edge in a technology-driven landscape.

Actionable strategic priorities for medical device leaders to align clinical evidence, manufacturing resilience, digital capabilities, and payer engagement for sustainable adoption

Industry leaders should pursue a coordinated set of strategies that align clinical evidence, manufacturing resilience, and commercial execution to capture clinical trust and institutional adoption. First, invest in targeted clinical studies and registry participation that demonstrate device performance across the specific applications most relevant to institutional partners, including both short-term acute support and longer-term destination therapy scenarios. Concurrently, accelerate human factors testing and clinician workflow integration to reduce training burdens and minimize adverse events during transition to ambulatory or home-based care. Second, strengthen supplier diversification and regional manufacturing relationships to reduce exposure to policy-driven cost shifts and supply disruptions; where possible, qualify secondary vendors and consider strategic inventory positioning to preserve continuity of care.

Third, develop tiered service and reimbursement narratives that quantify reductions in readmission, improvement in functional status, and the value of remote monitoring for early complication detection, enabling productive discussions with payers and hospital procurement teams. Fourth, prioritize digital capabilities by embedding telemetry and analytics that support predictive maintenance and clinical decision support, while ensuring robust cybersecurity and data governance. Finally, pursue collaborative models with health systems, academic centers, and payers that spread implementation risk, facilitate evidence generation, and create repeatable deployment pathways. By integrating these actions, leaders can align product design, evidence development, and commercial models to the operational realities of contemporary cardiac care.

A comprehensive, validated research approach combining primary clinician engagement, systematic secondary review, supply chain mapping, and cross-validated analytical techniques to ensure robust insights

A rigorous research methodology for analyzing mechanical circulatory support technologies blends primary stakeholder engagement, systematic secondary review, and data triangulation to validate findings and identify gaps. Primary research includes structured interviews with clinicians across cardiac surgery, cardiology, critical care, perfusionists, and nursing leadership, along with discussions with supply chain managers, biomedical engineers, and hospital procurement officers to capture operational realities. Secondary research synthesizes peer-reviewed clinical literature, regulatory filings, clinical trial registries, device labeling and instructions for use, and standards issued by relevant regulatory authorities to contextualize product capabilities and safety considerations.

Analytical approaches incorporate comparative technology assessments, lifecycle and service model analysis, and supply chain mapping that traces critical component origins and potential single-point vulnerabilities. Triangulation of qualitative insights and technical documentation ensures robustness, while scenario analysis explores implications of policy shifts, reimbursement changes, and technological breakthroughs. Quality controls include cross-validation of key findings with multiple expert sources and iterative review cycles with clinical advisors to ensure clinical and operational accuracy. This methodology balances depth with practical relevance, providing stakeholders with evidence-based insights that support strategic decision-making and operational planning.

Synthesis of clinical, operational, and commercial imperatives that define a practical roadmap for translating device innovation into durable patient and institutional outcomes

The mechanical circulatory support landscape is at an inflection point where technological progress, evolving care models, and policy dynamics intersect to create both opportunity and complexity for stakeholders. Advances in pump design, remote monitoring, and biocompatible materials are expanding the clinical utility of devices and enabling new care pathways outside traditional intensive care settings. At the same time, regional diversity in regulatory regimes, procurement behaviors, and infrastructure capacity requires tailored commercialization and deployment strategies. Policy changes that influence trade and tariff environments further underline the need for manufacturing and procurement agility to maintain device availability and cost-effectiveness.

For clinicians, manufacturers, and health system leaders, the path forward rests on aligning robust clinical evidence with service models that support safe, scalable adoption. Investments in human factors, clinician training, and remote monitoring capabilities will determine how quickly ambulatory and home-based models can be implemented without compromising patient safety. Simultaneously, commercial success will hinge on resilient supply chains, targeted regional strategies, and collaborative partnerships that accelerate evidence generation and reimbursement acceptance. In sum, stakeholders who proactively integrate clinical, operational, and commercial planning will be best positioned to translate technological potential into sustained patient benefit and institutional value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical MCS Device Market, by Product Type

  • 8.1. Biventricular Assist Device
  • 8.2. Extracorporeal Membrane Oxygenation
  • 8.3. Left Ventricular Assist Device
  • 8.4. Right Ventricular Assist Device
  • 8.5. Total Artificial Heart

9. Medical MCS Device Market, by Technology

  • 9.1. Continuous Flow
    • 9.1.1. Axial Flow
    • 9.1.2. Centrifugal Flow
  • 9.2. Pulsatile Flow

10. Medical MCS Device Market, by Mobility

  • 10.1. Portable
    • 10.1.1. Implantable
    • 10.1.2. Wearable
  • 10.2. Stationary

11. Medical MCS Device Market, by Application

  • 11.1. Bridge To Recovery
    • 11.1.1. Long-Term
    • 11.1.2. Short-Term
  • 11.2. Bridge To Transplant
  • 11.3. Destination Therapy
  • 11.4. Palliative Care

12. Medical MCS Device Market, by End User

  • 12.1. Ambulatory Care Centers
  • 12.2. Home Care Settings
  • 12.3. Hospitals
    • 12.3.1. Cardiac Care Units
      • 12.3.1.1. Adult ICU
      • 12.3.1.2. Pediatric ICU
    • 12.3.2. Intensive Care Units

13. Medical MCS Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical MCS Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical MCS Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical MCS Device Market

17. China Medical MCS Device Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Abiomed, Inc.
  • 18.7. Alcon, Inc.
  • 18.8. B. Braun Melsungen AG
  • 18.9. Baxter International Inc.
  • 18.10. Becton, Dickinson and Company
  • 18.11. Berlin Heart GmbH
  • 18.12. Boston Scientific Corporation
  • 18.13. Edwards Lifesciences Corporation
  • 18.14. Fresenius Medical Care AG & Co. KGaA
  • 18.15. GE HealthCare
  • 18.16. Getinge AB
  • 18.17. Intuitive Surgical, Inc.
  • 18.18. Johnson & Johnson
  • 18.19. Koninklijke Philips N.V.
  • 18.20. LivaNova PLC
  • 18.21. Medtronic plc
  • 18.22. Nipro Corporation
  • 18.23. Siemens Healthineers AG
  • 18.24. Stryker Corporation
  • 18.25. SynCardia Systems, LLC
  • 18.26. Terumo Corporation
  • 18.27. Zimmer Biomet Holdings, Inc.
  • 18.28. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL MCS DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL MCS DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL MCS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY TOTAL ARTIFICIAL HEART, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY AXIAL FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY AXIAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY AXIAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CENTRIFUGAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PULSATILE FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PULSATILE FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PULSATILE FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY LONG-TERM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY LONG-TERM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY LONG-TERM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY SHORT-TERM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY SHORT-TERM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY SHORT-TERM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY DESTINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PALLIATIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PALLIATIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PALLIATIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY ADULT ICU, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY ADULT ICU, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY ADULT ICU, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PEDIATRIC ICU, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PEDIATRIC ICU, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY PEDIATRIC ICU, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY INTENSIVE CARE UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY INTENSIVE CARE UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY INTENSIVE CARE UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. GCC MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 195. GCC MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 196. GCC MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 199. GCC MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GCC MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 201. GCC MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 224. G7 MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. G7 MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 228. G7 MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 229. G7 MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 232. G7 MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. G7 MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. G7 MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. NATO MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 239. NATO MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 240. NATO MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 241. NATO MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. NATO MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 243. NATO MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. NATO MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 245. NATO MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL MEDICAL MCS DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA MEDICAL MCS DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY CONTINUOUS FLOW, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY BRIDGE TO RECOVERY, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA MEDICAL MCS DEVICE MARKET SIZE, BY CARDIAC CARE UNITS, 2018-2032 (USD MILLION)